Christopher L Plaisier

Dr. Christopher L Plaisier

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2006 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
AGAnatole Ghazalpour
Anatole Ghazalpour
SDSudheer Doss
Sudheer Doss
BZBin Zhang
Bin Zhang
SWSusanna Wang
Susanna Wang
CPChristopher L Plaisier
Christopher L Plaisier
SHSteve Horvath
Steve Horvath
Systems biology approaches that are based on the genetics of gene expression have been fruitful in identifying genetic regulatory loci related to complex traits. We use microarray and genetic marker data from an F2 mouse intercross to examine the large-scale organization of the gene co-expression network in liver, and annotate several gene modules in terms of 22 physiological traits. We identify chromosomal loci (referred to as module quantitative trait loci, mQTL) that perturb the modules and describe a novel approach that integrates network properties with genetic marker information to model gene/trait relationships. Specifically, using the mQTL and the intramodular connectivity of a body weight–related module, we describe which factors determine the relationship between gene expression profiles and weight. Our approach results in the identification of genetic targets that influence gene modules (pathways) that are related to the clinical phenotypes of interest. Obesity is a major pub lic health concern in many developed countries. While some people appear to stay lean no matter what or how much they eat, others appear to be genetically predisposed to obesity. The genetic similarity between mouse and human makes the mouse a promising mammalian model system to study obesity. Advantages of mouse models include the ability to control diet/environment and easy access to relevant tissues for gene expression studies. Mouse cross studies have implicated dozens of chromosomal regions that contain weight-predisposing genes, and gene expression studies have yielded hundreds of body weight–related genes. In this study, the authors use a gene network–based approach for integrating clinical traits, genetic marker data, and gene expression data. Instead of focusing on individual genes, the authors provide a systems-level view of a module of genes related to body weight. The resulting model allows them to characterize weight-related genes utilizing network concepts (intramodular connectivity) and genetic concepts (module quantitative trait locus). This integrative genomics approach provides new insights into the relationship between gene expression and body weight.

26 January 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ALAlan Lloyd
Alan Lloyd
CPChristopher L Plaisier
Christopher L Plaisier
DCDana Carroll
Dana Carroll
GDGary N. Drews
Gary N. Drews
Targeted mutagenesis is an essential tool of reverse genetics that could be used experimentally to investigate basic plant biology or modify crop plants for improvement of important agricultural traits. Although targeted mutagenesis is routine in several model organisms including yeast and mouse, efficient and widely usable methods to generate targeted modifications in plant genes are not currently available. In this study we investigated the efficacy of a targeted-mutagenesis approach based on zinc-finger nucleases (ZFNs). In this procedure, ZFNs are used to generate double-strand breaks at specific genomic sites, and subsequent repair produces mutations at the break site. To determine whether ZFNs can cleave and induce mutations at specific sites within higher plant genomes, we introduced a construct carrying both a ZFN gene, driven by a heat-shock promoter, and its target into the Arabidopsis genome. Induction of ZFN expression by heat shock during seedling development resulted in mutations at the ZFN recognition sequence at frequencies as high as 0.2 mutations per target. Of 106 ZFN-induced mutations characterized, 83 (78%) were simple deletions of 1–52 bp (median of 4 bp), 14 (13%) were simple insertions of 1–4 bp, and 9 (8%) were deletions accompanied by insertions. In 10% of induced individuals, mutants were present in the subsequent generation, thus demonstrating efficient transmission of the ZFN-induced mutations. These data indicate that ZFNs can form the basis of a highly efficient method for targeted mutagenesis of plant genes.

1 December 2015 in Cell Reports
Verified
Journal Article
Open access
CTChad M. Toledo
Chad M. Toledo
YDYu Ding
Yu Ding
PHPia Hoellerbauer
Pia Hoellerbauer
RDRyan J. Davis
Ryan J. Davis
RBRyan Basom
Ryan Basom
PPPatrick J. Paddison
Patrick J. Paddison
To identify therapeutic targets for glioblastoma (GBM), we performed genome-wide CRISPR-Cas9 knockout (KO) screens in patient-derived GBM stem-like cells (GSCs) and human neural stem/progenitors (NSCs), non-neoplastic stem cell controls, for genes required for their in vitro growth. Surprisingly, the vast majority GSC-lethal hits were found outside of molecular networks commonly altered in GBM and GSCs (e.g., oncogenic drivers). In vitro and in vivo validation of GSC-specific targets revealed several strong hits, including the wee1-like kinase, PKMYT1/Myt1. Mechanistic studies demonstrated that PKMYT1 acts redundantly with WEE1 to inhibit cyclin B-CDK1 activity via CDK1-Y15 phosphorylation and to promote timely completion of mitosis in NSCs. However, in GSCs, this redundancy is lost, most likely as a result of oncogenic signaling, causing GBM-specific lethality.

28 June 2012 in Genome Research
Verified
Journal Article
Open access
PDF file
CPChristopher L Plaisier
Christopher L Plaisier
MPMin Pan
Min Pan
NBNitin Baliga
Nitin Baliga
Genes regulated by the same miRNA can be discovered by virtue of their coexpression at the transcriptional level and the presence of a conserved miRNA-binding site in their 3′ UTRs. Using this principle we have integrated the three best performing and complementary algorithms into a framework for inference of regulation by miRNAs (FIRM) from sets of coexpressed genes. We demonstrate the utility of FIRM by inferring a cancer–miRNA regulatory network through the analysis of 2240 gene coexpression signatures from 46 cancers. By analyzing this network for functional enrichment of known hallmarks of cancer we have discovered a subset of 13 miRNAs that regulate oncogenic processes across diverse cancers. We have performed experiments to test predictions from this miRNA-regulatory network to demonstrate that miRNAs of the miR-29 family (miR-29a, miR-29b, and miR-29c) regulate specific genes associated with tissue invasion and metastasis in lung adenocarcinoma. Further, we highlight the specificity of using FIRM inferences to identify miRNA-regulated genes by experimentally validating that miR-767-5p, which partially shares the miR-29 seed sequence, regulates only a subset of miR-29 targets. By providing mechanistic linkage between miRNA dysregulation in cancer, their binding sites in the 3′UTRs of specific sets of coexpressed genes, and their associations with known hallmarks of cancer, FIRM, and the inferred cancer miRNA-regulatory network will serve as a powerful public resource for discovery of potential cancer biomarkers.

1 March 2010 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CRCasey E. Romanoski
Casey E. Romanoski
SLSangderk Lee
Sangderk Lee
MKMichelle J. Kim
Michelle J. Kim
LILeslie Ingram-Drake
Leslie Ingram-Drake
CPChristopher L Plaisier
Christopher L Plaisier
ALAldons J. Lusis
Aldons J. Lusis

11 September 2009 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
CPChristopher L Plaisier
Christopher L Plaisier
SHSteve Horvath
Steve Horvath
AHAdriana Huertas-Vazquez
Adriana Huertas-Vazquez
ICIvette Cruz-Bautista
Ivette Cruz-Bautista
MHMiguel F Herrera
Miguel F Herrera
PPPäivi Pajukanta
Päivi Pajukanta
We hypothesized that a common SNP in the 3' untranslated region of the upstream transcription factor 1 (USF1), rs3737787, may affect lipid traits by influencing gene expression levels, and we investigated this possibility utilizing the Mexican population, which has a high predisposition to dyslipidemia. We first associated rs3737787 genotypes in Mexican Familial Combined Hyperlipidemia (FCHL) case/control fat biopsies, with global expression patterns. To identify sets of co-expressed genes co-regulated by similar factors such as transcription factors, genetic variants, or environmental effects, we utilized weighted gene co-expression network analysis (WGCNA). Through WGCNA in the Mexican FCHL fat biopsies we identified two significant Triglyceride (TG)-associated co-expression modules. One of these modules was also associated with FCHL, the other FCHL component traits, and rs3737787 genotypes. This USF1-regulated FCHL-associated (URFA) module was enriched for genes involved in lipid metabolic processes. Using systems genetics procedures we identified 18 causal candidate genes in the URFA module. The FCHL causal candidate gene fatty acid desaturase 3 (FADS3) was associated with TGs in a recent Caucasian genome-wide significant association study and we replicated this association in Mexican FCHL families. Based on a USF1-regulated FCHL-associated co-expression module and SNP rs3737787, we identify a set of causal candidate genes for FCHL-related traits. We then provide evidence from two independent datasets supporting FADS3 as a causal gene for FCHL and elevated TGs in Mexicans. By integrating a genetic polymorphism with genome-wide gene expression levels, we were able to attribute function to a genetic polymorphism in the USF1 gene. The USF1 gene has previously been associated with a common dyslipidemia, FCHL. FCHL is characterized by elevated levels of total cholesterol, triglycerides, or both. We demonstrate that this genetic polymorphism in USF1 contributes to FCHL disease risk by modulating the expression of a group of genes functionally related to lipid metabolism, and that this modulation is mediated by USF1. One of the genes whose expression is modulated by USF1 is FADS3, which was also implicated in a recent genome-wide association study for lipid traits. We demonstrated that a genetic polymorphism from the FADS3 region, which was associated with triglycerides in a GWAS study of Caucasians, was also associated with triglycerides in Mexican FCHL families. Our analysis provides novel insight into the gene expression profile contributing to FCHL disease risk, and identifies FADS3 as a new gene for FCHL in Mexicans.